References
- Kutz K, Nuesch E, Rosenthaler J. Pharmacokinetics of SMS 201–995 in healthy subjects. Scand J Gastroenterol 1986; 21(suppl 119)65–72
- Sandler L M, Burrin J M, Joplin G F, Bloom S R. Effect of high dose somatostatin analogue on growth hormone concentrations in acromegaly. Br Med J 1988; 296: 751–752
- Larsson L-I, Hoist J J, Kühl C, et al. Pancreatic somatostatinoma. Clinical features and physiological implications. Lancet 1977; 1: 666–668
- Thorsgaard Pedersen N, Halgreen H. Simultaneous assessment of fat maldigestion and fat malabsorption by a double-isotope method using fecal radioactivity. Gastroenterology 1987; 92: 885–890
- van de Kamer J H, Ten Bokkel Huinink H, Weijers H A. Rapid method for determination of fat in faeces. J Biol Chem 1949; 177: 347–355
- Creutzfeldt W, Lambcke B, Folsch U R, Schleser S, Koop I. Effect of somatostatin analogue (SMS 201–995, Sandostatin) on pancreatic secretion in humans. Am J Med 1987; 82(suppl 5B)49–54
- Köhler E, Berlinger C, Dettweiler S, Whitehouse I I, Gyr K. Effect of a new somatostatin analogue on pancreatic function in healthy volunteers. Pancreas 1986; 1: 154–159
- Fisher R S, Rock E, Levin G, Malmud L. Effect of somatostatin on gall bladder emptying. Gastroenterology 1987; 92: 885–890
- Krejs G J, Browne R, Raskin P. Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes. Gastroenterology 1980; 78: 26–31
- Pointer V H, Hengl G, Bayer P M, Flegel U. Hem-mung des postprandialen triglyzeridanstiegs im serum durch somatostatin beim menschen. Wien Klin Wochenschr 1977; 89: 224–227
- Schusdiziarra V, Harris V, Arimura A, Unger R H. Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients. Endocrinology 1979; 104: 1705–1708
- Fuessl H S, Carolan G, Williams G, Bloom S R. Effect of a long-acting somatostatin analogue (SMS 201–995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-coecum transit time in man. Digestion 1987; 36: 101–107
- Wahren J, Eriksson L S. The influence of a long-acting somatostatin analogue on splanchnic haemo-dynamics and metabolism in healthy subjects and patients with liver cirrhosis. Scand J Gastroenterol 1986; 21(suppl 119)103–108
- Mortensen P E, Olsen J, Bousfield R, Agerskov K, Christiansen J. Effect of a somatostatin analogue, SMS 201–995, on 133Xe clearance from colonic mucosa in unanesthetized man. Scand J Gastroenterol 1987; 22: 1056–1058
- Barnes J, Long R G, Adrian T E, et al. Effect of a long-acting octapeptide analogue of somatostatin on growth hormone and pancreatic and gastrointestinal hormones in man. Clin Sci 1981; 61: 653–656
- Ganda O P, Weir G C, Soeldner J S, et al. ‘Soma-tostinoma’: a somatostatin-containing tumor of the endocrine pancreas. N Engl J Med 1977; 296: 963–967
- Stöckmann F, Richter G, Lembcke B, Conlon M, Creutzfeldt W. Long-term treatment of patients with endocrine gastrointestinal tumors with the somatostatin analogue SMS 201–995. Scand J Gastroenterol 1986; 21(suppl 119)230–237
- Lembcke B, Creutzfeldt W, Schleser S, Ebert R, Shaw C, Koop I. Effect of the somatostatin analogue sandostatin (SMS 201–995) on gastrointestinal, pancreatic and biliary function and hormonal release in normal men. Digestion 1987; 36: 108–124